| manufacturing capacity | 51200 MT |
|---|
BSE filing, NSE: SUDEEPPHRM. Summary written from the filing by ALFA Finder's alert engine.
Sudeep Pharma Ltd: key numbers
- Share price
- ₹1,130.10
- Market cap
- ₹12,764 Cr
- Revenue (annual)
- ₹642.3 Cr
- Net profit (annual)
- ₹172.9 Cr
- P/E (TTM)
- 67.8×Sector 48.7×
- Promoter holding
- 76.15%+0.00% QoQ
- FII holding
- 2.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudeep Pharma Ltd
All →Sudeep Pharma Earnings Call Transcript: Key Takeaways
Sudeep Pharma delivered record quarterly revenue led by its Pharma Food Nutrition (PFN) segment, though specialty ingredients face short-term headwinds from the pause of a government rice program.
Sudeep Pharma Investor Presentation: Key Takeaways
Q2FY27 revenue Rs196.7cr (+21% YoY), record EBITDA Rs73.2cr (+32%, 37.2% margin), PAT Rs51.8cr (+11%). Battery-materials pivot and Nandesari FDA approval are the strategic highlights.
Sudeep Pharma Q2 FY27 Results: Net Profit ₹51.8 Cr, Up 10.7% YoY
Sudeep Pharma Ltd reported revenue from operations of ₹196.7 Cr (+20.9% YoY) and net profit of ₹51.8 Cr (+10.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹51.8 Cr · +10.7% YoY
Sudeep Pharma Board Meeting Date
Sudeep Pharma has scheduled its Board meeting for 28 October 2026 to approve Q1 and H1 FY27 financial results. No results or monetary figures are disclosed in this intimation.
Sudeep Pharma Other Announcement
The company submitted the mandatory compliance certificate under Regulation 74(5) for the quarter ended September 30, 2026.
Sudeep Pharma Management Change
Mr. Sendhil Pani has ceased to be a Senior Management Personnel of Sudeep Pharma Ltd effective October 2, 2026. This follows the completion of his contractual arrangements.
Other capacity expansion announcements
All →Aditya Vision Capacity Expansion
Aditya Vision opened five new showrooms, taking its total to 219. The expansion enters Madhya Pradesh and West Bengal, its fifth and sixth states.
- new showrooms
- 5.0 showrooms
FlySBS Aviation Capacity Expansion: ₹13.98 Cr Investment
FlySBS Aviation will induct a Hawker 900XP 9-seater aircraft in October 2026, funded by Rs.13.98 Crore from IPO proceeds. Fleet rises from two to three aircraft.
- Value
- ₹13.98 Cr
- Execution
- October 2026
- fleet capacity (9-seater aircraft)
- 1.0 aircraft
Greenply Industries Capacity Expansion: ₹30 Cr Investment
Greenply's board approved further investment of up to INR 30 crore in its wholly owned subsidiary Greenply Sandila Private Limited for plywood capacity expansion. The funds will be paid in one or more tranches by Q4 FY2028.
- Value
- ₹30.00 Cr
- Execution
- Q4 of FY 2028, in one or more tranches
Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Greenply Industries Capacity Expansion
Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.
- Execution
- By Q4 of FY 2028
- plywood manufacturing capacity
- 15.0 million sq mtr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units